5AM Partners VII, LLC
CIK: 0001873545
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Skye Bioscience, Inc.
Discretionary Trading P&L
Holdings
Transaction History (25 total)
- Sep 23, 2026SKYE
Skye Bioscience, Inc.
Sale(S)Indirect4.5K shares at avg. $1.61$7K - Sep 23, 2026SKYE
Skye Bioscience, Inc.
Sale(S)Indirect114.9K shares at avg. $1.61$185K - Sep 22, 2026SKYE
Skye Bioscience, Inc.
Sale(S)Indirect27.6K shares at avg. $1.65$46K - Sep 22, 2026SKYE
Skye Bioscience, Inc.
Sale(S)Indirect1.1K shares at avg. $1.65$2K - Sep 16, 2026SKYE
Skye Bioscience, Inc.
Sale(S)Indirect32.6K shares at avg. $1.91$62K - Sep 16, 2026SKYE
Skye Bioscience, Inc.
Sale(S)Indirect1.3K shares at avg. $1.91$2K - Aug 20, 2026SKYE
Skye Bioscience, Inc.
Sale(S)Indirect1.2K shares at avg. $0.32$370.88 - Aug 20, 2026SKYE
Skye Bioscience, Inc.
Sale(S)Indirect46 shares at avg. $0.32$14.72 - Aug 20, 2026SKYE
Skye Bioscience, Inc.
Sale(S)Indirect6.5K shares at avg. $0.32$2K - Aug 19, 2026SKYE
Skye Bioscience, Inc.
Sale(S)Indirect57.5K shares at avg. $0.35$20K - Aug 19, 2026SKYE
Skye Bioscience, Inc.
Sale(S)Indirect409 shares at avg. $0.35$143.15 - Aug 19, 2026SKYE
Skye Bioscience, Inc.
Sale(S)Indirect10.3K shares at avg. $0.35$4K - Aug 18, 2026SKYE
Skye Bioscience, Inc.
Sale(S)Indirect253.1K shares at avg. $0.38$96K - Aug 18, 2026SKYE
Skye Bioscience, Inc.
Sale(S)Indirect1.8K shares at avg. $0.38$695.4 - Aug 18, 2026SKYE
Skye Bioscience, Inc.
Sale(S)Indirect45.1K shares at avg. $0.38$17K - Aug 22, 2025SKYE
Skye Bioscience, Inc.
Sale(S)Indirect6.5K shares at avg. $3.42$22K - Aug 22, 2025SKYE
Skye Bioscience, Inc.
Sale(S)Indirect164K shares at avg. $3.42$561K - Aug 21, 2025SKYE
Skye Bioscience, Inc.
Sale(S)Indirect2.3K shares at avg. $3.57$8K - Aug 21, 2025SKYE
Skye Bioscience, Inc.
Sale(S)Indirect58.6K shares at avg. $3.57$209K - Sep 13, 2024SKYE
Skye Bioscience, Inc.
Sale(S)Indirect79 shares at avg. $6.06$478.74 - Sep 13, 2024SKYE
Skye Bioscience, Inc.
Sale(S)Indirect11.8K shares at avg. $6.06$71K - Sep 13, 2024SKYE
Skye Bioscience, Inc.
Sale(S)Indirect2K shares at avg. $6.06$12K - Sep 11, 2024SKYE
Skye Bioscience, Inc.
Sale(S)Indirect1.4K shares at avg. $6.60$10K - Sep 11, 2024SKYE
Skye Bioscience, Inc.
Sale(S)Indirect214.6K shares at avg. $6.60$1.4M - Sep 11, 2024SKYE
Skye Bioscience, Inc.
Sale(S)Indirect36.5K shares at avg. $6.60$241K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 23, 2026 | SKYE Skye Bioscience, Inc. | Sale(S) | 4,528 | $1.61 | $7,290 | Indirect |
| Sep 23, 2026 | SKYE Skye Bioscience, Inc. | Sale(S) | 114,851 | $1.61 | $184,910 | Indirect |
| Sep 22, 2026 | SKYE Skye Bioscience, Inc. | Sale(S) | 27,612 | $1.65 | $45,560 | Indirect |
| Sep 22, 2026 | SKYE Skye Bioscience, Inc. | Sale(S) | 1,088 | $1.65 | $1,795 | Indirect |
| Sep 16, 2026 | SKYE Skye Bioscience, Inc. | Sale(S) | 32,607 | $1.91 | $62,279 | Indirect |
| Sep 16, 2026 | SKYE Skye Bioscience, Inc. | Sale(S) | 1,285 | $1.91 | $2,454 | Indirect |
| Aug 20, 2026 | SKYE Skye Bioscience, Inc. | Sale(S) | 1,159 | $0.32 | $371 | Indirect |
| Aug 20, 2026 | SKYE Skye Bioscience, Inc. | Sale(S) | 46 | $0.32 | $15 | Indirect |
| Aug 20, 2026 | SKYE Skye Bioscience, Inc. | Sale(S) | 6,495 | $0.32 | $2,078 | Indirect |
| Aug 19, 2026 | SKYE Skye Bioscience, Inc. | Sale(S) | 57,476 | $0.35 | $20,117 | Indirect |
| Aug 19, 2026 | SKYE Skye Bioscience, Inc. | Sale(S) | 409 | $0.35 | $143 | Indirect |
| Aug 19, 2026 | SKYE Skye Bioscience, Inc. | Sale(S) | 10,255 | $0.35 | $3,589 | Indirect |
| Aug 18, 2026 | SKYE Skye Bioscience, Inc. | Sale(S) | 253,080 | $0.38 | $96,170 | Indirect |
| Aug 18, 2026 | SKYE Skye Bioscience, Inc. | Sale(S) | 1,830 | $0.38 | $695 | Indirect |
| Aug 18, 2026 | SKYE Skye Bioscience, Inc. | Sale(S) | 45,090 | $0.38 | $17,134 | Indirect |
| Aug 22, 2025 | SKYE Skye Bioscience, Inc. | Sale(S) | 6,470 | $3.42 | $22,127 | Indirect |
| Aug 22, 2025 | SKYE Skye Bioscience, Inc. | Sale(S) | 163,979 | $3.42 | $560,808 | Indirect |
| Aug 21, 2025 | SKYE Skye Bioscience, Inc. | Sale(S) | 2,314 | $3.57 | $8,261 | Indirect |
| Aug 21, 2025 | SKYE Skye Bioscience, Inc. | Sale(S) | 58,642 | $3.57 | $209,352 | Indirect |
| Sep 13, 2024 | SKYE Skye Bioscience, Inc. | Sale(S) | 79 | $6.06 | $479 | Indirect |
| Sep 13, 2024 | SKYE Skye Bioscience, Inc. | Sale(S) | 11,758 | $6.06 | $71,253 | Indirect |
| Sep 13, 2024 | SKYE Skye Bioscience, Inc. | Sale(S) | 2,000 | $6.06 | $12,120 | Indirect |
| Sep 11, 2024 | SKYE Skye Bioscience, Inc. | Sale(S) | 1,440 | $6.60 | $9,504 | Indirect |
| Sep 11, 2024 | SKYE Skye Bioscience, Inc. | Sale(S) | 214,556 | $6.60 | $1,416,070 | Indirect |
| Sep 11, 2024 | SKYE Skye Bioscience, Inc. | Sale(S) | 36,504 | $6.60 | $240,926 | Indirect |
1-25 of 25 transactions
About 5AM Partners VII, LLC
5AM Partners VII, LLC (SEC CIK 0001873545) files insider reports with the SEC as 10% Owner of Skye Bioscience, Inc. (SKYE).
Signal8 holds 5 ownership filings by 5AM Partners VII, LLC, all Form 4s, filed between Sep 13, 2024 and Sep 24, 2026. Those filings report 25 transactions, from Sep 11, 2024 to Sep 23, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on 5AM Partners VII, LLC's filings is in SAN FRANCISCO, CA.
Recent filings by 5AM Partners VII, LLC
- Sep 23, 2026: Open-market sales of SKYE shares (2 lines, Form 4, code S).
- Sep 22, 2026: Open-market sales of SKYE shares (2 lines, Form 4, code S).
- Sep 16, 2026: Open-market sales of SKYE shares (2 lines, Form 4, code S).
- Aug 20, 2026: Open-market sales of SKYE shares (3 lines, Form 4, code S).
- Aug 19, 2026: Open-market sales of SKYE shares (3 lines, Form 4, code S).
Other insiders filing for Skye Bioscience, Inc. (SKYE)
- Schwab Andrew J., Director
- DHILLON PUNIT, Chief Executive Officer
- Sharp John P, Chief Financial Officer
- Smith Karen L., Director
- Twitty Christopher, Chief Scientific Officer
- Jenkins Annalisa, Director